Paper35278
Approach to drug therapy for hypertension.
Kuchel OG and 3 others. Can Med Assoc J, 1979. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Approach to drug therapy for hypertension. Papers, record 35278. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35278
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antihypertensive Agents | Major topic |
| Hypertension | Major topic |
| Patient Care Planning | Major topic |
| Adrenergic beta-Antagonists | |
| Adult | |
| Aged | |
| Benzothiadiazines | |
| Clonidine | |
| Diuretics | |
| Guanidines | |
| Humans | |
| Hydralazine | |
| Methyldopa | |
| Middle Aged | |
| Patient Compliance | |
| Prazosin | |
| Reserpine | |
| Sodium Chloride Symporter Inhibitors | |
| Spironolactone | |
| Vasodilator Agents |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,053,475 | Hypertension: therapy as recommended by the national committees. | Angiology | 1976 | https://conductscience.org/library/papers/1053475 | PubMed |
| 2 | 1,256,484 | Propranolol in the treatment of hypertension. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1256484 | PubMed |
| 3 | 23,284 | Antihypertensive drugs: clinical pharmacology and therapeutic use. | Drugs | 1977 | https://conductscience.org/library/papers/23284 | PubMed |
| 4 | 235,842 | Adverse reactions and interactions limiting the use of antihypertensive drugs. | Am J Med | 1975 | https://conductscience.org/library/papers/235842 | PubMed |
| 5 | 4,404,062 | Medical management of primary hypertension. 3. | N Engl J Med | 1972 | https://conductscience.org/library/papers/4404062 | PubMed |
| 6 | 4,593,182 | Correlation of pathophysiology and pharmacotherapy in primary hypertension. | Am J Cardiol | 1973 | https://conductscience.org/library/papers/4593182 | PubMed |
| 7 | 57,611 | Antihypertensive pharmacotherapy. | Postgrad Med | 1976 | https://conductscience.org/library/papers/57611 | PubMed |
| 8 | 7,343 | Diseases of the cardiovascular system Hypertension--II. | Br Med J | 1976 | https://conductscience.org/library/papers/7343 | PubMed |
| 9 | 840,801 | Managing hypertension: the postgraduate medicine lecture. | Postgrad Med | 1977 | https://conductscience.org/library/papers/840801 | PubMed |
| 10 | 961,569 | Drugs in the management of hypertension. Part II. | Am Heart J | 1976 | https://conductscience.org/library/papers/961569 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 2,565,758 | Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. | CMAJ | 1989 | https://conductscience.org/library/papers/2565758 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35278
GET https://conductscience.org/api/papers/v1/35278/authors